Prof. Dr. Özlem Soran
After becoming a cardiologist (cardiovascular disease) in 1996, she specialized in cardiac insufficiency at the University of Pittsburgh. As a result of her work at the University of Pittsburgh, she started research proving the use of EECP therapy (fortified external counterpulsation) in cardiac insufficiency, and as a result of her studies in 2002, the FDA approved the use of EECP treatment in the treatment of cardiac insufficiency. The results of this research, led Özlem Soran to become the Director of the EECP Treatments Laboratory at the University of Pittsburgh in 2001 and become an authority on EECP Therapy and Cardiac Insufficiency in the world.
She has been invited to speak at over 120 scientific meetings, including American (American College of Cardiology, American Heart Association) and European Heart Congresses. She is the recipient of over ten scientific and academic awards. She also serves on the editorial board of 10 prestigious scientific journals of cardiology.
Another area in which Dr. Özlem Soran, who became an Associate Professor in 2004, focuses her research is on chronic cardiac insufficiency treatment and moniterization programs. In 2002, she won a $ 3 million research award from the US government (Medicare and Medicaid), and her research became one of the first three medical-guided studies at the American Heart Congress in 2009. She also became the first Turkish to be selected for the presentation of “Late Breaking Clinical Trial”. In 2004 and 2005, she was invited to “honors convocation”, at which the most successful faculty members are honored by the Pittsburgh University, and received a recognition award. She has over 130 presentations and publications in the field of cardiology.
Prof. Dr. Soran also holds an MA in Epidemiology from the University of Pittsburgh. She received her second associate professorship in the field of Epidemiology afterwards. One of her fields of interest is prevention of coronary artery disease.